EUVIMEDEUVIMED entdecken
Crossref

Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California

Nicola Manalili, Jenelle Merzon, Julia Alber iD, Adrienne Lent iD

American Journal of Health Promotion · 2025

DOI: 10.1177/08901171251315005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Health Promotion, 2025. Verfasst von Nicola Manalili und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology and Public Health, California Polytechnic State University San Luis Obispo, San Luis Obispo, CA, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Tobacco Use Cessation Devices, Smoking Cessation Agents. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Teacher Scholar Mini Grant at California Polytechnic State University San Luis Obispo, William and Linda Frost Fund at California Polytechnic State University San Luis Obispo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine associations between identified factors to accessing Food and Drug Administration-approved quit medication (FDAQM) and use among a sample of tobacco users.

Design

Cross-sectional, online survey.

Setting

County in Central California. Subjects Current adult tobacco users (n = 76). Measures Demographics self-reported likelihood of quitting in the next month, contacting a healthcare provider about quitting, time since last healthcare visit, provider asking about tobacco/nicotine use, provider advice to quit, provider FDAQM prescription and FDAQM use in the past year. Analysis Logistic regression.

Results

Those with a higher likelihood of quitting had a lower odds of FDAQM use (OR = 0.15, 95% CI = 0.03, 0.73) while those who had contacted a healthcare provider had a higher odds (OR = 15.39, 95% CI = 2.72, 87.05).

Conclusion

While the sample was limited, this research provides evidence in an understudied tobacco cessation area. More work is needed to understand the generalizability of these results and develop interventions that address these factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationTobacco Use Cessation DevicesSmoking Cessation AgentsHumansCaliforniaAdultMaleFemaleCross-Sectional StudiesMiddle AgedUnited StatesUnited States Food and Drug AdministrationYoung AdultSurveys and Questionnaires

Stichwörter der Autor:innen

health policyquit medicationssmokingtobacco cessation

Substanzen

Smoking Cessation Agents

Autor:innen und Institutionen

  • Department of Kinesiology and Public Health, California Polytechnic State University San Luis Obispo, San Luis Obispo, CA, USA.
  • Tobacco Control Program, County of San Luis Obispo Health Agency, San Luis Obispo, CA, USA.

ORCID-Profile: Julia Alber, Adrienne Lent

Förderung

  • Teacher Scholar Mini Grant at California Polytechnic State University San Luis Obispo
  • William and Linda Frost Fund at California Polytechnic State University San Luis Obispo

Zitieren

APA

Manalili, N., Merzon, J., Alber, J., & Lent, A. (2025). Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California. American Journal of Health Promotion. https://doi.org/10.1177/08901171251315005

Vancouver

Manalili N, Merzon J, Alber J, Lent A. Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California. American Journal of Health Promotion. 2025. doi:10.1177/08901171251315005

BibTeX
@article{Manalili2025,
  author = {Manalili, Nicola and Merzon, Jenelle and Alber, Julia and Lent, Adrienne},
  title = {Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California},
  journal = {American Journal of Health Promotion},
  year = {2025},
  doi = {10.1177/08901171251315005}
}
Kostenlos starten →